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Human herpesvirus-6Human herpesvirus-6 (HHV-6) is an important immunosuppressive and immunomodulatory virus that
primarily infects immune cells (mainly CD4+ T cells) and strongly suppresses the proliferation of infected
cells. Toll-like receptors are pattern-recognition receptors essential for the development of an appropriate
innate immune defense against infection. To understand the role of CD4+ T cells in the innate response to
HHV-6 infection and the involvement of TLRs, we used an in vitro infection model and observed that the
infection of CD4+ T cells resulted in the activation of JNK/SAPK via up-regulation of toll-like receptor 9
(TLR9). Associated with JNK activation, annexin V-PI staining indicated that HHV-6A was a strong inducer
of apoptosis. Apoptotic response associated cytokines, IL-6 and TNF-α also induced by HHV-6A infection.
© 2011 Elsevier Inc. All rights reserved.Introduction
Human herpesvirus-6 (HHV-6), which is widely spread in the
human population at a frequency of more than 90%, was isolated in
the blood of patients with AIDS or other lymphoproliferative disorders
(Salahuddin et al., 1986). Based on virological analysis, there are two
distinct variants (HHV-6A and HHV-6B). HHV-6B is a ubiquitous
virus and causes the common childhood disease exanthem subitum
(Yamanishi et al., 1988), whereas the seroprevalence rate and path-
ological features of HHV-6A is unknown.
HHV-6 is an important immunosuppressive virus that completely
replicates mainly in CD4+ T cells. After HHV-6 infection (Campadelli-
Fiume et al., 1999), interactions between the innate and adaptive
immune responses and immunoregulation may play pivotal roles
in the perpetuation of HHV-6 infection. Modulation of the host immune
responses represents an important mechanism whereby viruses create
a favorable environment for their growth and persistence. This is partic-
ularly important for agents like herpesviruses that typically persist in
their hosts for the entire lifetime.
The development of a successful immune response against invading
pathogens relies mostly on the effective detection of such invasion
by the host. Toll-like receptors (TLRs) are now believed to be crucial
sensors for the detection of potentially harmful foreign organismsrights reserved.(Janssens and Beyaert, 2003). Ten different human TLRs have been
identiﬁed, and each TLR recognizes distinct pathogen-associated
molecular patterns (PAMPs) (Fischer and Ehlers, 2008). Receptors
that recognize viral products or nucleic acids are expressed in endo-
somal membranes (e.g. TLR3, TLR7, TLR8, TLR9). TLR2 recognizes
peptidoglycan and glycolipids and TLR4 recognizes lipopolysaccharide.
These are expressed on the cytoplasmic membrane (Thompson and
Locarnini, 2007). Recognition of PAMPs by TLRs results in the activa-
tion of signaling events that induce the expression of effectormolecules,
such as cytokines and chemokines, which directly regulate immuno-
competent cells and control the activation of adaptive immune responses.
Certain TLRs are also expressed in T lymphocytes, and the respective
ligands can directly modulate T cell function. TLR2, TLR3, TLR5 and
TLR9 act as costimulatory receptors to enhance proliferation and/or
cytokine production of T cell receptor-stimulated T lymphocytes
(Kabelitz, 2007).
TLRs' signal transduction is achieved through the intracellular TLR
domain, resulting in the recruitment of myeloid differentiation factor
88(MyD88). Further downstream signaling events include activation
of serine/threonine kinase of the IRAK family, TRAF6. TRAF6 induces
the activation of TAK1 through K63-linked polyubiquitination. NF-κB
or AP-1 is then activated by the IKK complex or MAP kinases, respec-
tively (Zhu and Mohan, 2010). Recent studies have suggested that
viral infections may be modulated by mitogen-activated protein
kinase (MAPK) pathways, such as human immunodeﬁciency virus
type 1 (HIV-1) (Kumar et al., 1998), HSV-1 (Zachos et al., 1999),
human cytomegalovirus (HCMV) (Rodems and Spector, 1998), human
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et al., 2011). These MAPK family members include: the extracellular
signal-regulated kinases (ERKs), ERK1 and ERK2; JNKs/SAPKs, which
include p54 SAPK (SAPKα/β, JNK2/3) and p45 SAPK (SAPKγ, JNK1);
and the p38 MAP kinases (α, β, γ, and δ). JNK/SAPK and p38 MAPK
have been shown to phosphorylate a number of transcription factors
such as c-Jun and ATF-2. C-Jun is phosphorylated speciﬁcally by JNK/
SAPK, and ATF-2 can be phosphorylated by both JNK/SAPK and p38
MAPK (Gupta et al., 1995; Kyriakis et al., 1994).
Recently, various effects of viral infection on expression and sig-
naling of TLRs have been reported. TLR9 is known to be necessary for
a proper immune defense against bacteria of Streptococcus, Klebsiella,
and Legionella species as well as intracellular pathogens, including
viruses such as HSV-2 (McCluskie et al., 2006), CMV (Tabeta et al.,
2004), poxviruses (Samuelsson et al., 2008). TLR9 signaling is known
to be fully dependent on the recruitment of MyD88 to the receptor
following ligand binding in endosomal compartments. However,
the information about the regulation of TLRs by HHV-6 infection is
also limited. The current study was undertaken to investigate the
effects of HHV-6 infection on the expression and functions of TLRs in
CD4+ T cells. In this paper, we provide evidence that HHV-6 infection
can in fact modulate CD4+ T cells' intracellular TLR9 expression and
TLR9-mediated signaling for the development of an effective immune
response.Results
HHV-6A infection mediated TLR9 mRNA up-regulation in CD4+ T cell
In this report, we ﬁrst sought to determine whether HHV-6A in-
fection could also modulate intracellular TLR mRNA up-regulation
in human CD4+ T cells. So we screened the TLR1–10 mRNAs in HHV-
6A-infected CD4+ T cells and compared them with that in mock-
infected CD4+ T cells. We applied semi-quantitative RT-PCR to study
mRNA of TLRs transcripts in CD4+ T cells. The characteristics of primer
sets and controls are provided in Table 1. Human CD4+ T cells were
puriﬁed from freshly isolated PBMCs and TLR1–10 mRNAs were
measured for 1 h, 6 h, and 12 h after infected by HHV-6A. As shown
in Fig. 1A, our results showed that high levels of mRNA were restricted
to TLR1, TLR5, TLR6, TLR9, and low mRNA levels of TLR2, TLR3, TLR7
and TLR8 in CD4+ T cells. TLR9 mRNA level was signiﬁcantly increased
with HHV-6A infection compared to mock-infection at 1 h, 6 h, 12 h.Fig. 1. HHV-6-mediated TLR9 mRNA up-regulation in CD4+ T cell. (A) Semi-quantitative
RT-PCR analysis of TLR1–10 mRNAs in mock-infected and HHV-6A-infected CD4+ T
cells. The level of mRNA of TLR9 is higher in HHV-6A-infected CD4+ T cell than in mock-
infected CD4+ T cells. No TLR1–8 and TLR10 mRNA signal increased or decreased in
CD4+ T cells before and after HHV-6 infection. (B) The level of mRNA of TLR9 was signif-
icantly increased during the course of HHV-6-infection and showed a time dependent. The
level of mRNA for TLR9 was no change in mock-infcted CD4+ T cells collected in 1, 6, 12,
24, 48 h after mock-infection. (C) Level of mRNA of TLR9 gene was analyzed by real-
time PCR. Similar results were obtained, n=3; data are mean±s.e.m. *pb0.05, **pb0.01.
Table 1
Primer sequences and length of amplicons.
Gene Primer sequences Product size (bp)
TLR1 Forward: GGA GGC AAT GCT GCT GTT
Reverse: GCC CAA TAT GCC TTT GTT ATC CTG
120
TLR2 Forward: TGT TGC AAG CAG GAT CCA AAG
Reverse: CAC AAA GTA TGT GGC ATT GTC CAG
157
TLR3 Forward: GGA CTT TGA GGC GGG TGT T
Reverse: TGT TGA ACT GCA TGA TGT ACC TTG A
180
TLR4 Forward: AGG ATG ATG CCA GCA TGA TGT C
Reverse: TCA GGT CCA GGT TCT TGG TTG AG
198
TLR5 Forward: AAG ATG TCG GAG CCT CAG ATG
Reverse: GGG TCC CTG GTT GTT TAA AGA CTT C
181
TLR6 Forward: CAG AGT GAG TGG TGC CAT TAC GA
Reverse: AGC CTT CAG CTT GTG GTA CTT GTT G
138
TLR7 Forward: TCT TCA ACC AGA CCT CTA CAT TCC A
Reverse: GGA ACA TCC AGA GTG ACA TCA CAG
172
TLR8 Forward: GCG CTG CTG CAA GTT ACG GA
Reverse: TCG ACG ATT GCT GCA CTC TG
203
TLR9 Forward: GGG ACC TCG AGT GTG AAG CA
Reverse: CTG GAG CTC ACA GGG TAG GAA
258
TLR10 Forward: CTC CCA ACT TTG TCC AGA AT
Reverse: TGG TGG GAA TGC AAT AGA AT
132
β-actin Forward: TGG CAC CCA GCA CAA TGA A
Reverse: TGG CAC CCA GCA CAA TGA A
186
Fig. 3. HHV-6A infection stimulates JNK activation in CD4+ T cells. (A) CD4+ T cells
were infected with (MOI) of 10 virus DNA copies per cell and were cultured for the
indicated times post-infection. At each timepoint, cells were lysed and subjected to
sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), followed
by immunoblotting with paired antibodies using a chemiluminescent technique to
determine IκB-a phosphorylation and degradation with antibodies against IκB-a
(IκB) and phospho-IκB-a (pIκB); JNK phosphorylation with antibodies against JNK
(JNK) and phospho-JNK (pJNK); ERK phosphorylation with antibodies against ERK
(ERK) and phospho-ERK (pERK); and p38 phosphorylation with antibodies against
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before and after HHV-6A infection. As shown in Fig. 1B, results of
semi-quantitative RT-PCR showed that the expression of mRNA for
TLR9 appeared to be increased in HHV-6A-infected CD4+ T cells as
compared with the expression of mRNA for TLR9 in mock-infected
CD4+ T cells during the course of infection. Moreover, HHV-6A infec-
tion resulted in a fast up-regulation in intracellular TLR9 mRNA and
showed a time dependent induction pattern in CD4+ T cells. Our
results also showed HHV-6 mock-infection did not induce expression
of mRNA for TLR9 in CD4+ T cells collected in 1, 6, 12, 24, 48 h after
mock-infection.
To further conﬁrm that TLR9 mRNA was increased by HHV-6A in-
fection, we also performed quantitative real-time PCR to detect TLR9
mRNA levels. As shown in Fig. 1C, similar results were obtained. TLR9
mRNA increased continuously to 12 h after HHV-6A infection, which
was approximately a 6.4-fold increase compared with 0 h.
Taken together, these results demonstrated that CD4+ T cells
infected with HHV-6A could up-regulate mRNA of TLR9.
Activation of JNK/MAPK signaling in HHV-6-infected CD4+ T cells
Next, we examined the signaling downstream of TLR9 activation.
The intracellular signaling system of TLR9 in HHV-6A-infected and
mock-infected CD4+ T cells was further examined. MyD88 is an
important adaptor molecule required for signal transduction through
TLRs except for TLR3. As shown in Fig. 2, it appeared that the expression
of MyD88 was signiﬁcantly higher in HHV-6A-infected CD4+ T cells
than in mock-infected CD4+ T cells. Expression of MyD88was elevated
at 24 h (1.46-fold), 48 h (2.07-fold) and 72 h (6.73-fold) after HHV-6A
infection.
Except for TLR3, all TLRs ligation events recruit the adaptor MyD88,
followed by the IRAK family of protein kinases, leading to the activation
of TRAF6. TRAF6 induces the activation of TAK1 through K63-linked
polyubiquitination. NF-κB or AP-1 is then activated by the IKK complex
or MAP kinases, respectively. Therefore, CD4+ T cells lysates were
prepared for western blot analysis after HHV-6A infection. Western
blotting was utilized to examine the expression level of NF-κB subunit
IκBα, JNK, P38, ERK expression and phosphorylation status. As shown
in Fig. 3A, similar amounts of IκBα were detected after normalization
with GAPDH. We observed no change on phosphorylation level of IκBα.
In addition, we investigated whether MAPKs were activated in CD4+ T
cells infected with HHV-6A by Western blot analysis using anti-MAPKs
Abs against the phosphorylated forms of each protein. Clear signals of
themain isoforms of JNK activity, p46/JNK1 and p54/JNK2/3, were visible
at 24, 48 and 72 h in HHV-6A-infected CD4+ T cells compared to mock-
infected CD4+ T cells. In addition, blotting with an antibody detecting
both phosphorylated and unphosphorylated JNK indicated that the
amount of total JNK protein had not changed. Having shown that JNK
was activated in HHV-6A-infected CD4+ T cells, we aimed to determine
whether the p38 and ERKpathways are also activated following infection.Fig. 2.Western blotting reveals that the expression levels of MyD88 protein in HHV-
6-infected CD4+ T cells. Expression level of MyD88 was elevated at 24 h (1.46-fold),
48 h (2.07-fold) and 72 h (6.73-fold) post-infected with HHV-6A.
p38 (p38) and phospho-p38 (pP38). Exposure of CD4+ T cells to 10 moi HHV-6A
for 24 h resulted in an increase in phosphorylated JNK/SAPK. The phosphorylation
level gradually increased during the course of HHV-6-infection. Total intracellular
p38 and JNK/SAPK levels were not altered. (B) Activation of transcription factors
AP-1 and ATF-2 by HHV-6A. CD4+ T cells were infected with 10 moi HHV-6A and
were incubated for different time periods. An equal amount of total cell lysate from
each sample was subjected to western blot analysis with indicated antibodies. The
same blot was re-probed for GAPDH as an internal control. The levels of total c-Jun
and ATF-2 were not altered. Increases in ATF-2 and c-Jun phosphorylation were evident
in response to HHV-6A infection.Unlike JNK, the levels of ERK and p38, two other signaling effectors
associated with TLRs activation, remained unchanged in HHV-6A-
infected CD4+ T cells. All blots were probed with Ab recognizing
the housekeeping protein GAPDH to rule out that the differences
Fig. 4.HHV-6A infection induces apoptosis of CD4+ T cells. (A) CD4+ T cells were infected with HHV-6A for several time points (1 to 3 days). Apoptosis was analyzed by ﬂow cytometry.
(B) Each column and error bar represents the mean±SD of three independent experiments (**pb0.01).
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protein loading. Thus, HHV-6 infection induced activation of JNK/
SAPK signaling.
We further determined whether the signal produced by JNK/
SAPK was propagated to their corresponding downstream targets,
AP-1 and ATF-2. Increased phosphorylation of ATF-2 and c-Jun
were seen at 48 h and increased signiﬁcantly at 72 h after virus infec-
tion. The levels of total c-Jun and ATF-2 were not altered. These data
suggested that activation of the SAPK as a consequence of HHV-6A
infection led to a propagation of the signal to downstream targets
(Fig. 3B).HHV-6A infection induces apoptosis of CD4+ T cells
In the course of HHV-6A infection, especially on the third day, we
observed the phenomenon of cell death. To investigate the effect of
HHV-6A infection on apoptosis in CD4+ T cells, we stained cells
infected with HHV-6A with annexin-V-FITC and PI at 24, 48, and
72 h post-infection followed by analysis by ﬂow cytometry. Figs. 4A
and B showed that a high percentage of annexin-V positive cells
(apoptotic cells) in HHV-6A-infected cells were observed at 48 and
72 h compared to mock-infected CD4+ T cells. The percentage of
early apoptotic cells and late apoptotic cells reached 10.27% and
30.06% at 72 h post-infection, whereas, in mock-infected cells, the
percentage of early apoptotic cells and late apoptotic cells was
only1.40% and 2.66%, respectively.Fig.5. HHV-6A infection induced cytokine production. CD4+ T cells were cultured with
controls (mock) and HHV-6A for several time points (1 to 3 days), and culture super-
natants were collected and analyzed by ELISA. HHV-6A induced signiﬁcant amounts
of TNF-α, IL-6, and IL-10.HHV-6A infection induces cytokine production of CD4+ T cells
We examined the cytokines production of CD4+ T cells after HHV-
6A infection. CD4+ T cells were stimulated with mock or HHV-6A for
24, 48 and 72 h, and supernatants were examined for cytokines by
ELISA. Data in Fig. 5 show that HHV-6A infection induced CD4+ T
cells to secrete IL-6, and TNF-α. We found that the levels of IL-8 in
the supernatants of CD4+ T cells infected by HHV-6A had no change
compared with the control (data not shown).Discussion
TLR9 is expressed in neutrophils (Hayashi et al., 2003), B cells
(Bernasconi et al., 2003), T cells, and monocytes (Hornung et al.,
2002), as well as in plasmacytoid dendritic cells (Krug et al., 2001).
Following DNA entry into the cells and binding to TLR9 in endosomal
compartments, recruitment of the adaptor protein MyD88 to the Toll/
IL-1R (TIR) domain of the receptor is triggered followed by the en-
gagement of other adaptor proteins of the IL-1R associated kinase
(IRAK) family and of TNFR-associated factor-6 (TRAF6). The engage-
ment of TLR9 leads to the activation of two important but distinct
intracellular signaling pathways involving, on the one side, members
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2003), and on the other side, IκB, resulting in respective activation of
the transcription factors AP-1 and NF-κB (Takeuchi and Akira, 2007).
Here, we detected TLR1–10mRNAs of CD4+ T cells, our results revealed
that CD4+ T cells infected with HHV-6A led to intracellular TLR mRNA
up-regulation, particularly that of TLR9. Similar to bacterial DNA, HHV-
6 DNA contains abundant deoxycytidylate phosphatedeoxyguanylate
(CpG) motifs. These motifs stimulated multiple cellular components of
the immune system through TLR9. TLR9 transduced intracellular signals
through MyD88, which initiated a signaling cascade leading to p-JNK
activation. Thus, TLR9 might provide pathways that link HHV-6A
recognition in CD4+ T cells, although the role of this TLR in viral infec-
tion in vivo remains to be determined.
The distinct classes ofMAPKs play important roles in various cellular
events including cell proliferation, differentiation and apoptosis. JNKs
are activated by diverse stimuli including DNA damage, heat-shock,
bacterial components, inﬂammatory cytokines and Fas (Leppa and
Bohmann, 1999). Our results showed that JNK/SAPK was strongly
phosphorylated by HHV-6A infection. Activated JNKs play an essential
role in the activation of transcriptional factors, such as c-Jun, ATF-2,
Elk-1 and Ets-2 (Bonny et al., 2001). In our study, phosphorylation
levels of ATF-2 and c-Jun in HHV-6-infected CD4+ T cells appeared to
be signiﬁcantly higher than those in mock-infected CD4+ T cell. ATF-2
and c-Jun phosphorylation was seen at 48 h and increased signiﬁcantly
at 72 h after HHV-6A infection. These data suggested that activation
of the JNK/SAPK as a consequence of HHV-6A infection led to a prop-
agation of the signal to downstream targets. Most recently, Murakami
reported that HHV-6 infection impaired toll-like receptor signaling
(Murakami et al., 2010). Although HHV-6 infection increased the
expression of mRNA for TLRs (TLR3, 4, 7) and their adaptor molecules
in HHV-6-infected DCs. HHV-6 infection impaired intracellular signaling
through TLRs in DCs to mediate immunomodulation. In our study, HHV-
6 infection could induce intracellular signaling through TLR9 in CD4+ T
cell. These results suggested that HHV-6 infection led to impairment or
activation TLRs intracellular signaling dependent on the different cell
types. HHV-6 infection may mediate immunomodulation through TLRs
intracellular signaling in HHV-6 infection cells. Because HHV-6 infection
induced phenotypic and functional alterations in DCs and apoptosis of
CD4+ T cells to modulate immune responses (Lusso, 2006).
Many regulatory molecules, such as the Bcl-2 family members and
ICE family proteases, have been shown to be involved in the control of
apoptosis (Henkart, 1996), but the exact regulatory mechanisms for
apoptosis remain unknown. Although our previous studies have shown
that HHV-6A induced cell apoptosis in cultured HSB-2 (T lymphocyte
cells) through the mitochondria-mediated, caspase-dependent apo-
ptosis pathway. Recently, studies have shown that JNK induction by
TNF-αand various environmental stresses suggested that JNK may
regulate gene expression or other biochemical functions in cells
under detrimental conditions (Yeh et al., 2008). One potential func-
tion of JNK may be the initiation of programmed cell death. HHV-6A
infection has been reported to induce apoptosis both in vivo and in
vitro in CD4+ T cells (Ichimi et al., 1999; Inoue et al., 1997; Yasukawa
et al., 1998). In this study, annexin V-PI staining indicated that HHV-
6A is a strong inducer of apoptosis. In our present study, it was not
clariﬁed whether the activation of JNK was a direct or a bystander
effect in apoptosis. JNK is a key regulator of many cellular event, many
studies have shown that JNK could induce apoptosis (Lehmann et al.,
2002; Lin, 2003; Mc Gee et al., 2002; Shaulian and Karin, 2002). In
the absence of NF-κB activation, prolonged JNK activation contributes
to TNF-α induced apoptosis(Liu and Lin, 2005). Based on the aforemen-
tioned theoretical basis, we thought the activation of JNK via up-
regulation toll-like receptor 9 (TLR9) after HHV-6A infection may play
a role in apoptosis of CD4+ T cells.
Interleukin (IL)-1α, interleukin-6 (IL-6), interleukin-8 (IL-8),
interleukin-12 (IL-12) and tumor necrosis factor α (TNF-α) have
been shown to mediate the apoptotic response, and their activationcan be mediated by p38 and JNK/SAPK signaling (Yeh et al., 2008).
This mechanism has been established for cytomegalovirus (Sedger
et al., 1999), adenovirus (Hall et al., 2002), HIV (Xu et al., 1999) and
HSV (Raftery et al., 1999). Finally, we determined the role of cytokines
in HHV-6A infection. Our results shown in this report demonstrate
that IL-6, TNF-α was signiﬁcantly induced by HHV-6A infection, and
showed a time dependent induction pattern in CD4+ T cells, however,
no secretion of IL-8 was observed (data not shown). Our results sug-
gested that the increased IL-6 and TNF-α may promote the apoptosis
of HHV-6A infected CD4+ T cells.
In summary, our in vitro results demonstrated that HHV-6A infec-
tion lead to activation of JNK, c-jun and ATF-2. We also found the phe-
nomenon that HHV-6A infection lead to apoptosis of the CD4+ T cells.
Since the TLR system is essential for recognition of various pathogens
and generation of innate immunity, disruption of TLR-mediated sig-
naling seems to be an effective strategy by which viruses can evade
the immunosurveillance system. Manipulating the TLR9 pathway
may thus provide a new approach for immunosuppression in HHV-
6 infection.
Materials and methods
Cells and viruses
HSB-2 cells (T cell lines) were cultured in RPMI 1640 medium
(GIBCO) containing 8% fetal calf serum (FCS, GIBCO). The GS strain
of HHV-6 variant A was propagated in HSB-2 cells as described previ-
ously (Li et al., 2011). HHV-6A cell-free viruses were prepared as de-
scribed previously (Dhepakson et al., 2002). Brieﬂy, when the
cytopathic effects were maximal, HHV-6A-infected HSB-2 cells were
frozen and thawed twice, then centrifuged at 2000 g for 20 min. The
supernatants were concentrated by ultracentrifugation at 80,000 g
for 2 h and then resuspended in a minimal volume of complete RPMI
1640 medium for experimental use. Viral titers were determined as
viral DNA equivalents by quantitative PCR and conﬁrmed by the virus
infection in the inoculated cells. A multiplicity of infection (MOI) of 10
virus DNA copies per cell was used for all the experiments.
Blood samples were provided by healthy volunteers. Immuno-
magnetic beads were used to prepare CD4+ T cells (Dynal). CD4+ T
cells were negatively isolated from fresh PBMCs. Purity of the CD4+
T cell population is higher than 95%, as determined by ﬂow cytometry
analysis. CD4+ T cells used in different experiments were maintained
in RPMI 1640 medium containing 10% of fetal calf serum and plated at
a concentration of 1×106 cells/ml respectively.
RNA extraction and semi-quantitative reverse transcription
CD4+ T cells were either mock-infected or infected with HHV-6A
for 1 h, 6 h, or 12 h, and harvested. Total RNA isolated from CD4+ T
cells was performed using Qiagen RNeasy Mini kit (Qiagen) accord-
ing to the manufacturer's standard protocol. Total RNA (1 ug) was
reverse-transcribed with a ﬁrst-strand synthesis system for RT-PCR
(Invitrogen). cDNA was ampliﬁed by PCR using the speciﬁc primers
listed in Table 1. PCR products were separated on a 2% agarose gel
and visualized under UV illumination after ethidium bromide staining.
The amount of RT-PCR product was corrected with β-actin expression.
Experimentswith series diluted template ampliﬁcation for 30–35 cycles
were just in the linear range of detection of the examined genes, so we
chose to amplify all examined genes for 35 cycles.
Real-time quantitative PCR analysis
Real-time quantitative PCR was performed in volume of 20 μl
ration mixture containing 10 μl SYBR Green PCR Master Mix, 2.5 μl of
cDNA, and 200 nM of primers using a 7500 Real-Time PCR System
(Applied Biosystems), and done in triplicate. Primers used for PCR
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mined by the Real-Time PCR System. Results were normalized to the
housekeeper β-actin as follows: ΔC=CtTLR−Ctβ-actin. Relative ex-
pression was calculated using the formula: 2−ΔΔCT and expressed
as arbitrary units.
Western blotting analysis
Mock-infected or HHV-6A-infected CD4+ T cells were collected at
the time points indicated in the ﬁgure legends. Cell lysates were pre-
pared and further subjected to SDS-PAGE electrophoresis. Proteins
were transfered to PVDF membranes (Millipore) and detected with
the corresponding primary and secondary antibodies. The exposure
was developed with an enhanced chemiluminescence kit (Applygen).
The antibodies used in Western blotting analysis include: anti-ERK1/
2, anti-phospho-Thr202/Tyr204 ERK1/2, anti-p38, anti-phospho-
Thr180/Tyr182 p38, anti-JNK, anti-ATF2, anti-phospho-Thr71 ATF2,
anti-phospho-Thr183/Tyr185 SAPK/JNK, anti-IκBα, anti-phospho-
Ser32/36 IκBα, anti-c-Jun, anti-phospho-Ser73 c-Jun, anti-MyD88 and
anti-GAPDH (Cell Signaling Technology).
Annexin V-propidium iodide (PI) staining
Apoptosis was measured using ﬂow cytometry to quantify the
levels of detectable phosphatidylserine on the outer membrane of
apoptotic cells. Mock-infected or HHV-6A-infected CD4+ T cells were
prepared as described previously. Brieﬂy, 1×106 cells were collected,
washed with PBS and resuspended in 200 μl PBS. Then 5 μl of Annexin
V-FITC (BenderMedSystems) and 5 μl of propidium iodide (PI) solution
(Bender) were added and incubated in the dark for 15 min. Following
incubation, the cells were analyzed by ﬂow cytometry. The Annexin
V-FITC and PI ﬂuorescence was analyzed by ﬂow cytometry. The
amount of early apoptosis and late apoptosis was determined as the
percentage of Annexin V+/PI− and Annexin V+/PI+ cells, respectively.
Cytokine detection
Culture supernatants of mock-infected or HHV-6A-infected CD4+
T cells at the indicated time points were processed immediately
after collection and stored at−70 °C for the subsequent measurement
of cytokine levels. The levels of IL-6, IL-8 and TNF-αin the culture
medium were measured using commercially available ELISA assay
kits (Bender) according to the manufacturer's protocol. All cytokine
assays were performed in triplicate.
Statistical analysis
Unless indicated otherwise, data were expressed as mean±stan-
dard deviation (SD). All statistical analyses were carried out using
the SPSS software (Version 16.0). The signiﬁcance between groups
was performed by one-way ANOVA followed by LSD post-hoc test.
P valuesb0.05 were statistically considered signiﬁcant.
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